Roivant Sciences's total assets for Q3 2024 were $5.79B, a decrease of -6.67% from the previous quarter. ROIV total liabilities were $256.38M for the fiscal quarter, a -59.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.